FDA grants approval to Clavis to include U.S. patients in phase II clinical trial of CP-4126 July 6, 2009
Phase II activity of masitinib with gemcitabine in pancreatic cancer leads to phase III study July 3, 2009
CytRx reports results from phase II trial of tamibarotene as third-line treatment for APL July 2, 2009
RSS